Cd34 8g12

Manufactured by BD

Sourced in United States

CD34 (8G12) is a lab equipment product. It is used for the detection and analysis of CD34 positive cells. CD34 is a cell surface glycoprotein that is expressed on hematopoietic stem and progenitor cells. The 8G12 clone is a monoclonal antibody that binds to the CD34 antigen.

Automatically generated - may contain errors

Lab products found in correlation

Cd45 j33, by Beckman Coulter (2 mentions) Cd105 43a3, by BioLegend (2 mentions) Af6 120, by Thermo Fisher Scientific (2 mentions)

2 protocols using cd34 8g12

Isolation and Characterization of Luci-eASCs

Check if the same lab product or an alternative is used in the 5 most similar protocols

Luci-eASCs were defined according to the criteria of the International Society for Cellular Therapy (43 (link)). Luci-eASCs were characterized by their immunophenotype; positive for CD73 (AD2), CD90 (5E10, both from Becton Dickinson), and CD105 (43A3, from Biolegend) and negative for CD14 (RM052, from Immunotech), CD34 (8G12, from Becton Dickinson), CD45 (J33, from Beckman Coulter), and HLA-DR (AF6-120.1, from eBiosciences).

Lopez-Santalla M., Mancheño-Corvo P., Escolano A., Menta R., DelaRosa O., Abad J.L., Büscher D., Redondo J.M., Bueren J.A., Dalemans W., Lombardo E, & Garin M.I. (2017). Biodistribution and Efficacy of Human Adipose-Derived Mesenchymal Stem Cells Following Intranodal Administration in Experimental Colitis. Frontiers in Immunology, 8, 638.

+ Open protocol

+ Expand

Luci-eASCs Characterization Criteria

Cited 1 time

Check if the same lab product or an alternative is used in the 5 most similar protocols

Luci-eASCs were defined according to the criteria of the International Society for Cellular Therapy [36 (link)]. Luci-eASCs were stained using antibodies for CD73 (AD2), CD90 (5E10, both from Becton Dickinson), CD105 (43A3, Biolegend, San Diego, CA, USA), CD14 (RM052, Immunotech, Monrovia, CA, USA), CD34 (8G12, Becton Dickinson, Franklin Lakes, NJ, USA), CD45 (J33, Beckman Coulter, Brea, CA, USA) and HLA-DR (AF6-120.1, eBiosciences, Waltham, MA, USA) [18 (link)].

Lopez-Santalla M., Mancheño-Corvo P., Escolano A., Menta R., Delarosa O., Redondo J.M., Bueren J.A., Dalemans W., Lombardo E, & Garin M.I. (2018). Comparative Analysis between the In Vivo Biodistribution and Therapeutic Efficacy of Adipose-Derived Mesenchymal Stromal Cells Administered Intraperitoneally in Experimental Colitis. International Journal of Molecular Sciences, 19(7), 1853.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!